Literature DB >> 19759131

Interaction of the vaccinia virus RNA polymerase-associated 94-kilodalton protein with the early transcription factor.

Zhilong Yang1, Bernard Moss.   

Abstract

A multisubunit RNA polymerase (RPO) encoded by vaccinia virus (VACV), in conjunction with specific factors, transcribes early, intermediate, and late viral genes. However, an additional virus-encoded polypeptide referred to as the RPO-associated protein of 94 kDa (RAP94) is tightly bound to the RPO for the transcription of early genes. Unlike the eight RPO core subunits, RAP94 is synthesized exclusively at late times after infection. Furthermore, RAP94 is necessary for the packaging of RPO and other components needed for early transcription in assembling virus particles. The direct association of RAP94 with NPH I, a DNA-dependent ATPase required for transcription termination, and the multifunctional poly(A) polymerase small subunit/2'-O-methyltransferase/elongation factor was previously demonstrated. That RAP94 provides a structural and functional link between the core RPO and the VACV early transcription factor (VETF) has been suspected but not previously demonstrated. Using VACV recombinants that constitutively or inducibly express VETF subunits and RAP94 with affinity tags, we showed that (i) VETF associates only with RPO containing RAP94 in vivo and in vitro, (ii) the association of RAP94 with VETF requires both subunits of the latter, (iii) neither viral DNA nor other virus-encoded late proteins are required for the interaction of RAP94 with VETF and core RPO subunits, (iv) different domains of RAP94 bind VETF and core subunits of RPO, and (v) NPH I and VETF bind independently and possibly simultaneously to the N-terminal region of RAP94. Thus, RAP94 provides the bridge between the RPO and proteins needed for transcription initiation, elongation, and termination.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19759131      PMCID: PMC2786748          DOI: 10.1128/JVI.01653-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

1.  The viral RNA polymerase H4L subunit is required for Vaccinia virus early gene transcription termination.

Authors:  M R Mohamed; E G Niles
Journal:  J Biol Chem       Date:  2001-03-06       Impact factor: 5.157

2.  Antibodies directed against an epitope in the N-terminal region of the H4L subunit of the vaccinia virus RNA polymerase inhibit both transcription initiation and transcription termination, in vitro.

Authors:  Mohamed R Mohamed; Linda A Christen; Edward G Niles
Journal:  Virology       Date:  2002-07-20       Impact factor: 3.616

3.  Interaction between the J3R subunit of vaccinia virus poly(A) polymerase and the H4L subunit of the viral RNA polymerase.

Authors:  M R Mohamed; D R Latner; R C Condit; E G Niles
Journal:  Virology       Date:  2001-02-01       Impact factor: 3.616

Review 4.  Development of 2A peptide-based strategies in the design of multicistronic vectors.

Authors:  Andrea L Szymczak; Dario A A Vignali
Journal:  Expert Opin Biol Ther       Date:  2005-05       Impact factor: 4.388

5.  Sedimentation of an RNA polymerase complex from vaccinia virus that specifically initiates and terminates transcription.

Authors:  S S Broyles; B Moss
Journal:  Mol Cell Biol       Date:  1987-01       Impact factor: 4.272

6.  Two nucleic acid-dependent nucleoside triphosphate phosphohydrolases from vaccinia virus. Nucleotide substrate and polynucleotide cofactor specificities.

Authors:  E Paoletti; B Moss
Journal:  J Biol Chem       Date:  1974-05-25       Impact factor: 5.157

7.  Purification of mRNA guanylyltransferase and mRNA (guanine-7-) methyltransferase from vaccinia virions.

Authors:  S A Martin; E Paoletti; B Moss
Journal:  J Biol Chem       Date:  1975-12-25       Impact factor: 5.157

8.  The vaccinia virus bifunctional gene J3 (nucleoside-2'-O-)-methyltransferase and poly(A) polymerase stimulatory factor is implicated as a positive transcription elongation factor by two genetic approaches.

Authors:  D R Latner; Y Xiang; J I Lewis; J Condit; R C Condit
Journal:  Virology       Date:  2000-04-10       Impact factor: 3.616

9.  Purification and characterization of a transcription termination factor from vaccinia virions.

Authors:  S Shuman; S S Broyles; B Moss
Journal:  J Biol Chem       Date:  1987-09-05       Impact factor: 5.157

10.  Effect of selected mutations in the C-terminal region of the vaccinia virus nucleoside triphosphate phosphohydrolase I on binding to the H4L subunit of the viral RNA polymerase and early gene transcription termination in vitro.

Authors:  Sarah C Piacente; Linda A Christen; Mohamed Ragaa Mohamed; Edward G Niles
Journal:  Virology       Date:  2003-05-25       Impact factor: 3.616

View more
  14 in total

1.  Genome-wide analysis of the 5' and 3' ends of vaccinia virus early mRNAs delineates regulatory sequences of annotated and anomalous transcripts.

Authors:  Zhilong Yang; Daniel P Bruno; Craig A Martens; Stephen F Porcella; Bernard Moss
Journal:  J Virol       Date:  2011-04-13       Impact factor: 5.103

2.  Ribosome Profiling Reveals Translational Upregulation of Cellular Oxidative Phosphorylation mRNAs during Vaccinia Virus-Induced Host Shutoff.

Authors:  Aimei Dai; Shuai Cao; Pragyesh Dhungel; Yizhao Luan; Yizhi Liu; Zhi Xie; Zhilong Yang
Journal:  J Virol       Date:  2017-02-14       Impact factor: 5.103

3.  Interactions of the vaccinia virus A19 protein.

Authors:  P S Satheshkumar; L Renee Olano; Carl H Hammer; Ming Zhao; Bernard Moss
Journal:  J Virol       Date:  2013-07-24       Impact factor: 5.103

4.  Cholesterol Flux Is Required for Endosomal Progression of African Swine Fever Virions during the Initial Establishment of Infection.

Authors:  Miguel Ángel Cuesta-Geijo; Michele Chiappi; Inmaculada Galindo; Lucía Barrado-Gil; Raquel Muñoz-Moreno; José L Carrascosa; Covadonga Alonso
Journal:  J Virol       Date:  2015-11-25       Impact factor: 5.103

5.  RNA Polymerase Mutations Selected during Experimental Evolution Enhance Replication of a Hybrid Vaccinia Virus with an Intermediate Transcription Factor Subunit Replaced by the Myxoma Virus Ortholog.

Authors:  Carey A Stuart; Erik K Zhivkoplias; Tatiana G Senkevich; Linda S Wyatt; Bernard Moss
Journal:  J Virol       Date:  2018-09-26       Impact factor: 5.103

6.  Vaccinia virions deficient in transcription enzymes lack a nucleocapsid.

Authors:  Baron D H McFadden; Nissin Moussatche; Karen Kelley; Byung-Ho Kang; Richard C Condit
Journal:  Virology       Date:  2012-09-01       Impact factor: 3.616

7.  Biochemical analysis of the multifunctional vaccinia mRNA capping enzyme encoded by a temperature sensitive virus mutant.

Authors:  Jessica Tate; Rachel L Boldt; Baron D McFadden; Susan M D'Costa; Nicholas M Lewandowski; Amber N Shatzer; Paul Gollnick; Richard C Condit
Journal:  Virology       Date:  2015-10-20       Impact factor: 3.616

8.  JaPaFi: A Novel Program for the Identification of Highly Conserved DNA Sequences.

Authors:  Aliya Sadeque; Marina Barsky; Francesco Marass; Peter Kruczkiewicz; Chris Upton
Journal:  Viruses       Date:  2010-08-31       Impact factor: 5.818

Review 9.  Orthopoxvirus targets for the development of new antiviral agents.

Authors:  Mark N Prichard; Earl R Kern
Journal:  Antiviral Res       Date:  2012-03-08       Impact factor: 10.103

Review 10.  Cloak and Dagger: Alternative Immune Evasion and Modulation Strategies of Poxviruses.

Authors:  Susanna R Bidgood; Jason Mercer
Journal:  Viruses       Date:  2015-08-21       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.